Waukesha County Department Of Health And Human Services is a mental health and substance abuse rehab center located at 514 Riverview Avenue in the 53188 zip code in Waukesha, WI.
It is operated by the local government. Waukesha County Department Of Health And Human Services provides buprenorphine maintenance, relapse prevention from naltrexone and naltrexone administration. Some of the treatment approaches used by Waukesha County Department Of Health And Human Services include rational emotive behavioral therapy, anger management and trauma counseling. Waukesha County Department Of Health And Human Services provides IOT, outpatient methadone/buprenorphine or naltrexone treatment and regular outpatient treatment. It also provides inpatient treatment for co-occurring mental health and substance use disorders and residential treatment for substance use. Other addiction treatment offered includes treatment for gambling disorder.
Here are the full facility listing details on Waukesha County Department of Health and Human Services in Waukesha, WI:
Types of Care:
- residential substance use treatment
- inpatient treatment for co-occurring mental health and substance use disorders
Service Settings:
- outpatient rehab
- IOT
- outpatient methadone/buprenorphine or naltrexone treatment
- regular outpatient treatment
Opioid Medications used in Treatment:
- Buprenorphine clinical treatment
- Naltrexone used in Treatment
External Opioid Medications Source:
- Personal physician/health care provider
Type of Alcohol Use Disorder Treatment:
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Administers medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment:
- Personal physician/health care provider
Type Of Treatment:
- buprenorphine maintenance
- prescribes suboxone
- naltrexone administration
- relapse prevention from naltrexone
Pharmacotherapies:
- Acamprosate (Campral)
- Disulfiram (Antabuse)
- Buprenorphine with naloxone (Ex. Suboxone)
- Buprenorphine without naloxone
- Naltrexone (oral)
- Naltrexone (extended-release, injectable naltrexone - Vivitrol)
- Medications for psychiatric disorders
- Clonidine
Treatment Approaches:
- anger management
- brief intervention services
- CBT
- dialectical behavior therapy
- motivational interviewing
- rational emotive behavioral therapy
- relapse prevention treatment
- substance use counseling approach
- trauma counseling
- 12 step rehabilitation
Facility Ownership:
License/Certification/Accreditation:
- State substance abuse agency
- State mental health department
Payment/Insurance/Funding Accepted:
- Accepts Federal funding
- Accepts Medicare
- Accepts Medicaid
- Accepts private health insurance
- Accepts self-payment
- Accepts state health insurance
Payment Assistance Available:
Special Programs/ Population Groups Supported:
- teen rehab
- transitional-age young adults
- dual diagnosis treatment
Assessment/Pre-treatment:
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Interim services for clients
- Outreach to persons in the community
Screening & Testing:
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Screening for mental disorders
- Screening for substance use
Transitional Services:
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
- Outcome follow-up after discharge
Ancillary Services:
- case management
- housing services
- mental health services
- self-help groups
- social skills training
- transportation assistance
- group meetings
Other Addictions Treatment:
- treatment for gambling disorder
Counseling Services and Education:
- individual counseling services
- group counseling
- substance use education
Tobacco/Screening Services:
- Non-nicotine smoking/tobacco cessation medications
- Screening for tobacco use
- Smoking/tobacco cessation counseling
Facility Smoking Policy:
- Smoking permitted in designated area
Gender Accepted:
Call (888) 303-2026 to get 24/7 help with treatment.
SPONSORED AD
